通达股份：2025年前三季度净利润约1.32亿元

Group 1 - Company Tongda Co., Ltd. reported a revenue of approximately 6.066 billion yuan for the first three quarters of 2025, representing a year-on-year increase of 40.78% [1] - The net profit attributable to shareholders of the listed company was approximately 132 million yuan, showing a year-on-year increase of 83.29% [1] - Basic earnings per share reached 0.251 yuan, which is an increase of 83.61% compared to the previous year [1] Group 2 - As of the report, the market capitalization of Tongda Co., Ltd. is 4.5 billion yuan [2] - The Chinese innovative drug sector has seen overseas licensing sales reach 80 billion US dollars this year [2] - There is a contrast in the biopharmaceutical secondary market being active while the primary market is experiencing a fundraising slowdown [2]